These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 26333353)

  • 21. Cryptic Diversity of Malassezia pachydermatis from Healthy and Diseased Domestic Animals.
    Puig L; Castellá G; Cabañes FJ
    Mycopathologia; 2016 Oct; 181(9-10):681-8. PubMed ID: 27283291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Azole and terbinafine susceptibility testing of Malassezia pachydermatis in Japan.
    Murayama N; Kano R
    J Vet Med Sci; 2023 Mar; 85(3):383-385. PubMed ID: 36724970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
    Carrillo-Muñoz AJ; Rojas F; Tur-Tur C; de Los Ángeles Sosa M; Diez GO; Espada CM; Payá MJ; Giusiano G
    Mycoses; 2013 Sep; 56(5):571-5. PubMed ID: 23496653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal susceptibility of
    Núñez AH; Hidalgo FG; Morales PC; Silva VE; Thomson PE; Castro RA
    Open Vet J; 2022; 12(1):99-104. PubMed ID: 35342729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro growth versus inhibition of growth of Malassezia pachydermatis in the presence of the antibacterial drug gentamicin.
    Buommino E; Baroni A; Parisi A; Borriello FE; Caputo P; Donnarumma G; Nizza S; Nocera FP; Fiorito F; De Martino L
    J Med Microbiol; 2015 Feb; 64(Pt 2):180-4. PubMed ID: 25627206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of in vitro inhibitory activity of hydrogen peroxide on the growth of Malassezia pachydermatis and to compare its efficacy with commercial ear cleaners.
    Marrero EJ; Silva FA; Rosario I; Déniz S; Real F; Padilla D; Díaz EL; Acosta-Hernández B
    Mycoses; 2017 Oct; 60(10):645-650. PubMed ID: 28557001
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of carvacrol, cinnamaldehyde and thymol combined with antifungals against Malassezia pachydermatis.
    Schlemmer KB; Jesus FPK; Tondolo JSM; Weiblen C; Azevedo MI; Machado VS; Botton SA; Alves SH; Santurio JM
    J Mycol Med; 2019 Dec; 29(4):375-377. PubMed ID: 31455580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An azole-resistant isolate of Malassezia pachydermatis.
    Nijima M; Kano R; Nagata M; Hasegawa A; Kamata H
    Vet Microbiol; 2011 Apr; 149(1-2):288-90. PubMed ID: 21074337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic Tandem Quadruplication is Associated with Ketoconazole Resistance in
    Kim M; Cho YJ; Park M; Choi Y; Hwang SY; Jung WH
    J Microbiol Biotechnol; 2018 Nov; 28(11):1937-1945. PubMed ID: 30562885
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro evaluation of Malassezia pachydermatis susceptibility to azole compounds using E-test and CLSI microdilution methods.
    Cafarchia C; Figueredo LA; Iatta R; Colao V; Montagna MT; Otranto D
    Med Mycol; 2012 Nov; 50(8):795-801. PubMed ID: 22471886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.
    Watanabe S; Koike A; Kano R; Nagata M; Chen C; Hwang CY; Hasegawa A; Kamata H
    J Vet Med Sci; 2014 Apr; 76(4):579-81. PubMed ID: 24334863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malassezia infections in humans and animals: pathophysiology, detection, and treatment.
    Velegraki A; Cafarchia C; Gaitanis G; Iatta R; Boekhout T
    PLoS Pathog; 2015 Jan; 11(1):e1004523. PubMed ID: 25569140
    [No Abstract]   [Full Text] [Related]  

  • 33. ERG11 Gene Variability and Azole Susceptibility in Malassezia pachydermatis.
    Díaz L; Castellá G; Bragulat MR; Cabañes FJ
    Mycopathologia; 2023 Apr; 188(1-2):21-34. PubMed ID: 36495417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RAPD differentiation of Malassezia spp. from cattle, dogs and humans.
    Duarte ER; Hamdan JS
    Mycoses; 2010 Jan; 53(1):48-56. PubMed ID: 19298360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of medicinal essential oils against pathogenic Malassezia sp. isolates.
    Khosravi AR; Shokri H; Fahimirad S
    J Mycol Med; 2016 Mar; 26(1):28-34. PubMed ID: 26597143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro susceptibility testing of Malassezia pachydermatis to gentamicin.
    Silva FA; Ferrer O; Déniz S; Rosario I; Conde-Felipe M; Díaz EL; Acosta-Hernández B
    Vet Dermatol; 2017 Aug; 28(4):348-e76. PubMed ID: 28251703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro combination of antifungal agents against Malassezia pachydermatis.
    Schlemmer KB; de Jesus FPK; Loreto ES; Farias JB; Alves SH; Ferreiro L; Santurio JM
    Med Mycol; 2019 Apr; 57(3):324-327. PubMed ID: 29924372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Agar Diffusion Procedures for Susceptibility Testing of Malassezia pachydermatis: Evaluation of Mueller-Hinton Agar Plus 2 % Glucose and 0.5 µg/ml Methylene Blue as the Test Medium.
    Pasquetti M; Chiavassa E; Tizzani P; Danesi P; Peano A
    Mycopathologia; 2015 Oct; 180(3-4):153-8. PubMed ID: 26138434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
    Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
    Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic variability and phospholipase production of Malassezia pachydermatis isolated from dogs with diverse grades of skin lesions.
    Machado ML; Cafarchia C; Otranto D; Ferreira RR; Bianchi SP; Latrofa MS; Parisi A; Ferreiro L
    Med Mycol; 2010 Sep; 48(6):889-92. PubMed ID: 20105099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.